In addition, Dr. Norris is a Former Corporate Officer, Corporate Executive Vice President, and Worldwide Managing Director for Life Sciences Coaching and Consulting at Hill & Knowlton. With 83 offices in 46 countries, Hill and Knowlton is one of the world's largest marketing and management coaching and consulting firms. It represents many of the world's premier healthcare, life sciences, and healthcare-IT companies
Dr. Norris is a Director of Ischemix, a developer of next generation heart medicines for advancing ischemia-reperfusion therapy. In addition, he was CEO and is now Chairman of Needlebot, a developer and manufacturer of a next generation software search engine for searching and analyzing “unstructured text” contained in many sources, including nurses' notes, doctors' notes, medical records, medical literature, and clinical trial records, at both the Internet and Enterprise levels, as well as CEO and now Chairman of Norris Capital, a corporate finance and holding company and a boutique legal, regulatory, financial, marketing, and management/strategy coaching and consulting firm. He is also a Director of Last Call Ventures, LLC, a food-supplement company.
Dr. Norris was CEO and is now Chairman of FDDH (Food, Drug, Device, and Healthcare), a healthcare-delivery and healthcare-IT coaching firm, and was CEO and is now Chairman of the Joseph D. Norris, Esq., Health Law and Public Policy Fund. The Joseph D. Norris, Esq., Health Law and Public Policy Fund supports university scholarships for health law and public policy student training.
Dr. Norris is also the Founder and Former Faculty-Editor-in-Chief and CEO of the academic journal, The American Journal of Law and Medicine, which he founded at Harvard, MIT, and Boston University, and which is now housed at Boston University.Dr. Norris is the Former Chairman of Global MedChoices, which is developing a planned response to US healthcare reform at the convergence of three elements: (1) advanced healthcare-IT, (2) specialty surgical services, and (3) key medical tourism locations.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts